Recruiting Pneumonia Studies in Mobile
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression t...
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in adult hospitalized subjects with sC...
About Pneumonia Clinical Trials in Mobile
Pneumonia is an infection that inflames the air sacs in one or both lungs, which may fill with fluid or pus. It can range from mild to life-threatening. Treatment depends on the cause and severity, including antibiotics, antivirals, and supportive care.
There are currently 2 pneumonia clinical trials recruiting participants in Mobile, ALABAMA. These studies are seeking a combined 3,460 participants. Research is being sponsored by AstraZeneca, Biotest. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pneumonia Clinical Trials in Mobile — FAQ
Are there pneumonia clinical trials in Mobile?
Yes, there are 2 pneumonia clinical trials currently recruiting in Mobile, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Mobile?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you about next steps.
Are clinical trials in Mobile free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mobile studies also compensate for your time and travel.
What pneumonia treatments are being tested?
The 2 active trials in Mobile are testing new therapies including novel drugs, biologics, and treatment approaches for pneumonia.
Data updated March 2, 2026 from ClinicalTrials.gov